Bleichroeder LP’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bleichroeder LP’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34.7K	Hold	825	–	–	0.01%	72
2026 Q1	$21.8K	Hold	825	–	–	﹤0.01%	73
2025 Q4	$23.9K	Hold	825	–	–	﹤0.01%	69
2025 Q3	$22.9K	Hold	825	–	–	﹤0.01%	67
2025 Q2	$20.1K	Hold	825	–	–	﹤0.01%	70
2025 Q1	$17.1K	Hold	825	–	–	﹤0.01%	73
2024 Q4	$19.4K	Hold	825	–	–	﹤0.01%	70
2024 Q3	$21.1K	Hold	825	–	–	0.01%	67
2024 Q2	$19.4K	Hold	825	–	–	0.01%	68
2024 Q1	$23.7K	Hold	825	–	–	0.01%	71
2023 Q4	$27.1K	Hold	825	–	–	0.01%	65
2023 Q3	$23K	Hold	825	–	–	0.01%	60
2023 Q2	$28.1K	Hold	825	–	–	0.01%	68
2023 Q1	$24.8K	Hold	825	–	–	0.01%	66
2022 Q4	$23.3K	Hold	825	–	–	0.01%	69
2022 Q3	$27K	Hold	825	–	–	0.01%	77
2022 Q2	$26K	Buy	825 +500	+154%	+$17.5K	0.01%	83
2022 Q1	$15K	Buy	+325	New	+$15.5K	﹤0.01%	106

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bleichroeder LP's ARKG Position: Q2 2026 in Review

Bleichroeder LP held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 825 shares worth $34.7K. The position accounts for 0.01% of the portfolio, ranked #72.

Bleichroeder LP first reported a position in ARKG in Q1 2022 and has held it in 18 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Bleichroeder LP held 825 shares of ARK Genomic Revolution ETF worth $34.7K as of Q2 2026.
Bleichroeder LP left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
ARK Genomic Revolution ETF made up 0.01% of Bleichroeder LP's portfolio in Q2 2026, its #72 holding.
Bleichroeder LP first reported a position in ARK Genomic Revolution ETF in Q1 2022 and has held it in 18 quarters since.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Bleichroeder LP's 13F filing for Q2 2026, filed 13 Aug 2026.